ethidium has been researched along with Cancer of Prostate in 6 studies
Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.
ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the role of mtDNA in prostate cancer progression, we used LNCaP and PC-3 prostate carcinoma cells as experimental model." | 1.35 | Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma. ( Arbini, AA; Greco, M; Marra, E; Moro, L, 2008) |
| "These results suggest prostate cancers may be influenced by the CXCL12:CXCR4 pathway during metastasis." | 1.32 | The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. ( Arya, M; Klocker, H; Masters, J; McGurk, C; Patel, HR; Tatoud, R; Williamson, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 3 |
| Grigalavicius, M | 1 |
| Li, Y | 1 |
| Zhong, Y | 2 |
| Huang, R | 1 |
| Yu, D | 1 |
| Berge, V | 1 |
| Goscinski, MA | 2 |
| Kvalheim, G | 2 |
| Nesland, JM | 2 |
| Suo, Z | 2 |
| Lu, J | 1 |
| Axcrona, K | 1 |
| Eide, L | 1 |
| Syljuåsen, RG | 1 |
| Peng, Q | 1 |
| Wang, J | 1 |
| Zhang, H | 1 |
| Moro, L | 2 |
| Arbini, AA | 2 |
| Marra, E | 2 |
| Greco, M | 2 |
| Yao, JL | 1 |
| di Sant'Agnese, PA | 1 |
| Ogawa, T | 1 |
| Shiga, K | 1 |
| Hashimoto, S | 1 |
| Kobayashi, T | 1 |
| Horii, A | 1 |
| Furukawa, T | 1 |
| Arya, M | 1 |
| Patel, HR | 1 |
| McGurk, C | 1 |
| Tatoud, R | 1 |
| Klocker, H | 1 |
| Masters, J | 1 |
| Williamson, M | 1 |
6 other studies available for ethidium and Cancer of Prostate
| Article | Year |
|---|---|
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.
Topics: Cell Line, Tumor; Cell Lineage; Cell Movement; Cell Proliferation; DNA, Mitochondrial; Ethidium; Flo | 2017 |
MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Count; Cell Line, Tumor; Cell Movement | 2016 |
Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma.
Topics: Androgens; Apoptosis; Carcinogens; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Tran | 2008 |
Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
Topics: Anoikis; Blotting, Southern; Blotting, Western; Cell Line; Cell Movement; Cell Survival; Cyclooxygen | 2009 |
APAF-1-ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line.
Topics: Actins; Alternative Splicing; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase 9; | 2003 |
The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Topics: Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chemokines, CXC; DNA Primers; Dose-Response Relat | 2004 |